The National Administration of Drugs, Food, and Medical Technology (ANMAT) in Argentina has announced that it has approved Genzyme's Lemtrada for treating adult patients with the relapsing remitting form of multiple sclerosis. Genzyme had been looking to expand the market for the company’s MS drug, and Argentina, which is home to 8,000 people affected by MS, is an important market for Lemtrada.
Swiss based multinational drug producer Roche has announced that it will be partnering with both Inception and Versant in order to develop new drugs for patients suffering from multiple sclerosis, or MS.
Researchers at the University of Missouri have announced that they’ve discovered new properties in a compound initially created to lower cholesterol. The research team found that the compound could also stop the progression of breast cancer. It also killed cancer cells and stopped them from spreading throughout the body. The results of the team’s research were published in the Breast Cancer Research and Treatment journal.
British researchers at the University of East Anglia (UAE) have stated that they’ve discovered how the bacteria behind E. coli and salmonella build up a resistance to antibiotics. The researchers believe that they can develop a drug that switches off the bacteria’s ability to become resistant to antibiotic drugs. The results of the study were published in Nature.